Effectiveness of Pneumococcal Vaccination in Older Adults in Scotland
Author Information
Author(s): Mooney John D, Weir Amanda, McMenamin Jim, Ritchie Lewis D, Macfarlane Tatania V, Simpson Colin R, Ahmed Syed, Robertson Chris, Clarke Stuart C
Primary Institution: Health Protection Scotland
Hypothesis
What is the impact of pneumococcal vaccination on the incidence of invasive pneumococcal disease in those aged 65 and over during winter 2003/2004?
Conclusion
The introduction of the pneumococcal vaccine for those aged 65 and over in Scotland during winter 2003/2004 led to a significant reduction in the incidence of invasive pneumococcal disease in this age group.
Supporting Evidence
- Vaccination effectiveness was estimated at 61.7% using the screening method.
- A significant reduction in the incidence of invasive pneumococcal disease was observed in the 65+ age group.
- The number needed to vaccinate to prevent one case of IPD was 5206.
Takeaway
Vaccinating older people against pneumonia can help keep them from getting really sick. In Scotland, a new vaccine helped a lot of older folks stay healthy during the winter.
Methodology
A retrospective cohort design was used to assess the incidence rates of invasive pneumococcal disease and vaccination effectiveness in the targeted age group.
Potential Biases
Potential biases may arise from differences in health status between vaccinated and unvaccinated individuals.
Limitations
The study was limited to a single winter season, which may not capture long-term effects or variations in vaccine effectiveness over time.
Participant Demographics
The study focused on individuals aged 65 and over in Scotland.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI: 45.1, 73.2
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website